Mumps Vaccine Market Size, Share, Growth, and Industry Analysis, By Type (Child, Adult), By Application (Hospital Pharmacies, Retail Pharmacies), Regional Insights and Forecast to 2035

1 Mumps Vaccine Market Overview
1.1 Product Definition
1.2 Mumps Vaccine by Type
1.2.1 Global Mumps Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Child
1.2.3 Adult
1.3 Mumps Vaccine by Application
1.3.1 Global Mumps Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.4 Global Mumps Vaccine Market Size Estimates and Forecasts
1.4.1 Global Mumps Vaccine Revenue 2020-2031
1.4.2 Global Mumps Vaccine Sales 2020-2031
1.4.3 Global Mumps Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mumps Vaccine Market Competition by Manufacturers
2.1 Global Mumps Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mumps Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mumps Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mumps Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mumps Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mumps Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Mumps Vaccine, Date of Enter into This Industry
2.8 Global Mumps Vaccine Market Competitive Situation and Trends
2.8.1 Global Mumps Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mumps Vaccine Players Market Share by Revenue
2.8.3 Global Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mumps Vaccine Market Scenario by Region
3.1 Global Mumps Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mumps Vaccine Sales by Region: 2020-2031
3.2.1 Global Mumps Vaccine Sales by Region: 2020-2025
3.2.2 Global Mumps Vaccine Sales by Region: 2026-2031
3.3 Global Mumps Vaccine Revenue by Region: 2020-2031
3.3.1 Global Mumps Vaccine Revenue by Region: 2020-2025
3.3.2 Global Mumps Vaccine Revenue by Region: 2026-2031
3.4 North America Mumps Vaccine Market Facts & Figures by Country
3.4.1 North America Mumps Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mumps Vaccine Sales by Country (2020-2031)
3.4.3 North America Mumps Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mumps Vaccine Market Facts & Figures by Country
3.5.1 Europe Mumps Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mumps Vaccine Sales by Country (2020-2031)
3.5.3 Europe Mumps Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mumps Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Mumps Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mumps Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Mumps Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mumps Vaccine Market Facts & Figures by Country
3.7.1 Latin America Mumps Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mumps Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Mumps Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mumps Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Mumps Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mumps Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mumps Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mumps Vaccine Sales by Type (2020-2031)
4.1.1 Global Mumps Vaccine Sales by Type (2020-2025)
4.1.2 Global Mumps Vaccine Sales by Type (2026-2031)
4.1.3 Global Mumps Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Mumps Vaccine Revenue by Type (2020-2031)
4.2.1 Global Mumps Vaccine Revenue by Type (2020-2025)
4.2.2 Global Mumps Vaccine Revenue by Type (2026-2031)
4.2.3 Global Mumps Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Mumps Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mumps Vaccine Sales by Application (2020-2031)
5.1.1 Global Mumps Vaccine Sales by Application (2020-2025)
5.1.2 Global Mumps Vaccine Sales by Application (2026-2031)
5.1.3 Global Mumps Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Mumps Vaccine Revenue by Application (2020-2031)
5.2.1 Global Mumps Vaccine Revenue by Application (2020-2025)
5.2.2 Global Mumps Vaccine Revenue by Application (2026-2031)
5.2.3 Global Mumps Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Mumps Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 MedImmune
6.1.1 MedImmune Company Information
6.1.2 MedImmune Description and Business Overview
6.1.3 MedImmune Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 MedImmune Mumps Vaccine Product Portfolio
6.1.5 MedImmune Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Mumps Vaccine Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Company Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck & Co., Inc. Mumps Vaccine Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofi Mumps Vaccine Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Company Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Serum Institute of India Mumps Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Bavarian Nordic
6.6.1 Bavarian Nordic Company Information
6.6.2 Bavarian Nordic Description and Business Overview
6.6.3 Bavarian Nordic Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bavarian Nordic Mumps Vaccine Product Portfolio
6.6.5 Bavarian Nordic Recent Developments/Updates
6.7 Astellas Pharma India
6.7.1 Astellas Pharma India Company Information
6.7.2 Astellas Pharma India Description and Business Overview
6.7.3 Astellas Pharma India Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Astellas Pharma India Mumps Vaccine Product Portfolio
6.7.5 Astellas Pharma India Recent Developments/Updates
6.8 CSL Limited
6.8.1 CSL Limited Company Information
6.8.2 CSL Limited Description and Business Overview
6.8.3 CSL Limited Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CSL Limited Mumps Vaccine Product Portfolio
6.8.5 CSL Limited Recent Developments/Updates
6.9 Emergent BioSolutions
6.9.1 Emergent BioSolutions Company Information
6.9.2 Emergent BioSolutions Description and Business Overview
6.9.3 Emergent BioSolutions Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Emergent BioSolutions Mumps Vaccine Product Portfolio
6.9.5 Emergent BioSolutions Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Company Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GlaxoSmithKline Mumps Vaccine Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 Panacea Biotec, Ltd.
6.11.1 Panacea Biotec, Ltd. Company Information
6.11.2 Panacea Biotec, Ltd. Description and Business Overview
6.11.3 Panacea Biotec, Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Panacea Biotec, Ltd. Mumps Vaccine Product Portfolio
6.11.5 Panacea Biotec, Ltd. Recent Developments/Updates
6.12 Biological E Limited
6.12.1 Biological E Limited Company Information
6.12.2 Biological E Limited Description and Business Overview
6.12.3 Biological E Limited Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Biological E Limited Mumps Vaccine Product Portfolio
6.12.5 Biological E Limited Recent Developments/Updates
6.13 Bharat Biotech Ltd.
6.13.1 Bharat Biotech Ltd. Company Information
6.13.2 Bharat Biotech Ltd. Description and Business Overview
6.13.3 Bharat Biotech Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Bharat Biotech Ltd. Mumps Vaccine Product Portfolio
6.13.5 Bharat Biotech Ltd. Recent Developments/Updates
6.14 Novavax, Inc.
6.14.1 Novavax, Inc. Company Information
6.14.2 Novavax, Inc. Description and Business Overview
6.14.3 Novavax, Inc. Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Novavax, Inc. Mumps Vaccine Product Portfolio
6.14.5 Novavax, Inc. Recent Developments/Updates
6.15 Novartis
6.15.1 Novartis Company Information
6.15.2 Novartis Description and Business Overview
6.15.3 Novartis Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Novartis Mumps Vaccine Product Portfolio
6.15.5 Novartis Recent Developments/Updates
6.16 Sinovac Biotech, Ltd.
6.16.1 Sinovac Biotech, Ltd. Company Information
6.16.2 Sinovac Biotech, Ltd. Description and Business Overview
6.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Sinovac Biotech, Ltd. Mumps Vaccine Product Portfolio
6.16.5 Sinovac Biotech, Ltd. Recent Developments/Updates
6.17 Incepta Vaccine Limited
6.17.1 Incepta Vaccine Limited Company Information
6.17.2 Incepta Vaccine Limited Description and Business Overview
6.17.3 Incepta Vaccine Limited Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Incepta Vaccine Limited Mumps Vaccine Product Portfolio
6.17.5 Incepta Vaccine Limited Recent Developments/Updates
6.18 Valneva SE
6.18.1 Valneva SE Company Information
6.18.2 Valneva SE Description and Business Overview
6.18.3 Valneva SE Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Valneva SE Mumps Vaccine Product Portfolio
6.18.5 Valneva SE Recent Developments/Updates
6.19 VBI Vaccines
6.19.1 VBI Vaccines Company Information
6.19.2 VBI Vaccines Description and Business Overview
6.19.3 VBI Vaccines Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.19.4 VBI Vaccines Mumps Vaccine Product Portfolio
6.19.5 VBI Vaccines Recent Developments/Updates
6.20 PT Bio Farma
6.20.1 PT Bio Farma Company Information
6.20.2 PT Bio Farma Description and Business Overview
6.20.3 PT Bio Farma Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.20.4 PT Bio Farma Mumps Vaccine Product Portfolio
6.20.5 PT Bio Farma Recent Developments/Updates
6.21 Sharp & Dohme Corp
6.21.1 Sharp & Dohme Corp Company Information
6.21.2 Sharp & Dohme Corp Description and Business Overview
6.21.3 Sharp & Dohme Corp Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Sharp & Dohme Corp Mumps Vaccine Product Portfolio
6.21.5 Sharp & Dohme Corp Recent Developments/Updates
6.22 Bionity
6.22.1 Bionity Company Information
6.22.2 Bionity Description and Business Overview
6.22.3 Bionity Mumps Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Bionity Mumps Vaccine Product Portfolio
6.22.5 Bionity Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mumps Vaccine Industry Chain Analysis
7.2 Mumps Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mumps Vaccine Production Mode & Process Analysis
7.4 Mumps Vaccine Sales and Marketing
7.4.1 Mumps Vaccine Sales Channels
7.4.2 Mumps Vaccine Distributors
7.5 Mumps Vaccine Customer Analysis
8 Mumps Vaccine Market Dynamics
8.1 Mumps Vaccine Industry Trends
8.2 Mumps Vaccine Market Drivers
8.3 Mumps Vaccine Market Challenges
8.4 Mumps Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer